White House Intensifies Push for Lower Drug Prices Despite Congressional Resistance

0 comments

Trump Administration Intensifies Push for “Most-Favored Nation” Drug Pricing

WASHINGTON — Despite a cool reception from Congress, the White House is looking to intensify its pressure campaign on lawmakers to pass legislation that would codify a “most-favored nation” drug pricing policy, according to two Trump administration officials briefed on the conversations.

The administration has been pushing Republicans on Capitol Hill to pursue a sweeping health care package that would mean changes for providers, insurers, federal agencies, and patients. Much of the focus has been on creating legislation aimed at bringing the cost of medications to levels below what other peer countries pay.

So far, lawmakers have been far from receptive to such an idea, with Republicans characterizing the effort as government overreach that would be counter to free-market ideals, one official said. However, the White House isn’t backing down.

Background on Executive Power and Healthcare

Recent years have seen a significant expansion of executive power under President Trump, with some scholars suggesting a move towards authoritarianism 1. This trend has manifested in various ways, including attempts to bypass Congress and reshape federal departments 1. The current push for drug pricing reform is occurring within this context of a more assertive executive branch.

The Cabinet and Healthcare Policy

The current Secretary of the Treasury is Scott Bessent 2. While his direct involvement in healthcare policy isn’t specified, the Cabinet as a whole advises the President on matters relating to their respective offices 3. The Attorney General, Pam Bondi, previously focused on combating the opioid crisis as Florida’s Attorney General 2, demonstrating a past interest in healthcare-related issues.

Challenges in Congress

The administration’s efforts face significant hurdles in Congress. Republicans have expressed concerns that the “most-favored nation” drug pricing policy represents government overreach and interferes with free-market principles 4. This resistance highlights the ongoing tension between the executive branch’s desire to implement policy changes and the legislative branch’s role in shaping legislation.

1 NPR Staff. “How President Trump has challenged a constitutional foundation.” NPR, 23 Jan. 2026, https://www.npr.org/2026/01/23/g-s1-106562/trump-democracy-constitution-executive-power.

2 “The Cabinet.” The White House, https://www.whitehouse.gov/administration/the-cabinet/.

3 “The Administration.” Trump White House Archives, https://trumpwhitehouse.archives.gov/the-trump-administration/.

4 PBS. “What Congress is doing as Trump expands presidential power.” https://www.pbs.org/newshour/show/as-trump-expands-presidential-power-congress-divided-over-how-much-authority-to-cede.

Related Posts

Leave a Comment